Announcements Trials

Browse Landscape

Phase

Phase NA 44 Phase EARLY_PHASE1 5 Phase 2 5 Phase 4 2 Phase 1/2 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Myelodysplastic Syndromes 2 Lymphoma, Mantle-Cell 2 Lymphoma, Follicular 2 Leukemia, Myeloid, Accelerated Phase 2 Blast Crisis 2 Waldenstrom Macroglobulinemia 1 Triple Negative Breast Neoplasms 1 Skin Neoplasms 1 Prostatic Neoplasms 1 Osteosarcoma 1 Neuroendocrine Tumors 1 Neuroblastoma 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Hematologic Diseases 1 Graft vs Host Disease 1 Gastrointestinal Stromal Tumors 1 Breast Neoplasms 1

Interventions

Trastuzumab 61 Paclitaxel 57 Cyclophosphamide 44 pembrolizumab 35 Fulvestrant 34 Capecitabine 29 Carboplatin 27 Docetaxel 23 Letrozole 22 Doxorubicin 19 palbociclib 16 abemaciclib 16 pertuzumab 14 durvalumab 14 Filgrastim 13 Everolimus 13 ribociclib 12 Lapatinib 12 Gemcitabine 12 exemestane 11 eribulin 11 Vinorelbine 11 Albumin-Bound Paclitaxel 11 Bevacizumab 10 trastuzumab deruxtecan 9 neratinib 9 fludarabine 9 Taxes 9 Radiotherapy 9 Peripheral Blood Stem Cell Transplantation 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Breast Neoplasms × Blood Specimen Collection × Clear all

NCT04454528 2026-03-10

BreastVAX

Abramson Cancer Center at Penn Medicine

Phase 1/2 Active not recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡